AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
46.68
+0.47 (1.02%)
At close: Jan 21, 2026, 4:00 PM EST
46.68
0.00 (0.00%)
After-hours: Jan 21, 2026, 4:11 PM EST
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $1.29 billion as of January 21, 2026. Its market cap has increased by 220.80% in one year.
Market Cap
1.29B
Enterprise Value
1.37B
1-Year Change
220.80%
Ranking
Category
Stock Price
$46.68
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $1.29B, an increase of 318.69%. That is a compound annual growth rate of 17.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 1.26B | -5.77% |
| Dec 31, 2025 | 1.34B | 233.16% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
| Jan 26, 2017 | 308.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novavax | 1.33B |
| Immatics | 1.32B |
| EyePoint | 1.29B |
| Relay Therapeutics | 1.28B |
| DBV Technologies | 1.28B |
| Taysha Gene Therapies | 1.27B |
| Xeris Biopharma Holdings | 1.26B |
| Capricor Therapeutics | 1.25B |